ClaimsFiler cites Sept. 22 deadline in PROCEPT BioRobotics securities case
The shareholder alert concerns a securities class action over PROCEPT BioRobotics disclosures during a class period running from Feb. 28, 2024, through Feb. 25, 2026.
ClaimsFiler said investors in PROCEPT BioRobotics Corporation have until Sept. 22, 2026, to apply for lead-plaintiff status in a securities class action pending in the U.S. District Court for the Northern District of California.
ClaimsFiler described itself as a free shareholder information service and said the case covers purchasers of PROCEPT BioRobotics stock between Feb. 28, 2024, and Feb. 25, 2026, inclusive.
According to the PR Newswire alert, the case is titled Operating Engineers Construction Industry and Miscellaneous Pension Fund v. PROCEPT BioRobotics Corporation, No. 26-cv-07691. The notice says Procept and certain executives are accused of failing to disclose material information during the class period, in alleged violation of federal securities laws.
The alert cites allegations that U.S. handpiece sales materially exceeded procedures in every quarter since the first fiscal quarter of 2023. It also says the company accumulated more than 10,000 excess handpiece units in field inventory and that the imbalance was expected to drive a significant sequential decline in U.S. handpiece unit sales, causing the company to miss annual revenue guidance.
ClaimsFiler said the defendants’ statements about the company’s business, operations and prospects were allegedly materially false and misleading and/or lacked a reasonable basis. The item was presented as a shareholder alert, not a court filing or company statement.
The notice said investors can visit claimsfiler.com/cases/nasdaqgm-prct/ or call (833) 538-3604 for more information. It also said lawyers with Kahn Swick & Foti, LLC are available to discuss legal options.
The next deadline in the case is Sept. 22, 2026, for lead-plaintiff applications in the federal case in California.
Sources
Editorial note: This article was prepared with AI assistance and includes source attribution for reader review.
Comments ()